Regulation of Antiprotease and Antimicrobial Protein Secretion by Airway Submucosal Gland Serous Cells
Overview
Affiliations
Airway submucosal gland serous cells express the cystic fibrosis transmembrane conductance regulator (CFTR) and secrete antimicrobial, anti-inflammatory, and antioxidant molecules. In cystic fibrosis, diminished gland secretion may impair innate airway host defenses. We used Calu-3 cells as a serous cell model to study the types of proteins released, the pathways that release them, and the possible involvement of CFTR activity in protein release. Many proteins were secreted constitutively into the apical fluid and showed increased release to agonists. We identified some of them by high pressure liquid chromatography-mass spectrometry and reverse transcriptase PCR, including lysozyme, siderocalin (the protein NGAL), which inhibits bacterial growth by binding iron-containing siderophores, HSC-71, which is thought to have anti-inflammatory properties, and the serine protease inhibitors alpha-1-antitrypsin and alpha-1-antichymotrypsin, which may function as antimicrobials as well as play a potential role in diminishing the activation of epithelial Na(+) channels by serine proteases. We used an enzyme-linked immunosorbent assay to quantify lysozyme secretion by Calu-3 cells in response to various agonists and inhibitors. Forskolin increased the lysozyme secretion rate (J(lyz)) from 32 to 77 ng/hr/cm(2) (n = 36, p < 0.005). Thapsigargin increased J(lyz) from 40 to 63 ng/h/cm(2) (n = 16, p < 0.005), and forskolin plus thapsigargin further increased the forskolin-stimulated J(lyz) by 48% (n = 9, p < 0.05). 1-Ethyl-benzimidazolinone and carbachol were less effective. Glibenclamide inhibited basal and stimulated J(lyz), but clotrimazole was without effect. CFTR(inh)172 caused a small (15%) but significant inhibition of forskolin-stimulated J(lyz) without affecting basal J(lyz). Thus, Calu-3 cells secrete diverse proteins that in aggregate would be expected to suppress microbial growth, protect the airways from damage, and limit the activation of epithelial Na(+) channels via serine proteases.
Mahieu L, Van Moll L, De Vooght L, Delputte P, Cos P FEMS Microbiol Rev. 2024; 48(2).
PMID: 38409952 PMC: 10913945. DOI: 10.1093/femsre/fuae007.
Kato T, Radicioni G, Papanikolas M, Stoychev G, Markovetz M, Aoki K Sci Adv. 2022; 8(13):eabm9718.
PMID: 35363522 PMC: 10938572. DOI: 10.1126/sciadv.abm9718.
Physiology and pathophysiology of human airway mucus.
Hill D, Button B, Rubinstein M, Boucher R Physiol Rev. 2022; 102(4):1757-1836.
PMID: 35001665 PMC: 9665957. DOI: 10.1152/physrev.00004.2021.
Joo N, Cho H, Shinbashi M, Choi J, Milla C, Engelhardt J Sci Rep. 2021; 11(1):18828.
PMID: 34552115 PMC: 8458446. DOI: 10.1038/s41598-021-98122-5.
PAR-2-activated secretion by airway gland serous cells: role for CFTR and inhibition by .
McMahon D, Carey R, Kohanski M, Adappa N, Palmer J, Lee R Am J Physiol Lung Cell Mol Physiol. 2021; 320(5):L845-L879.
PMID: 33655758 PMC: 8174824. DOI: 10.1152/ajplung.00411.2020.